Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • BrightGene’s oral dual agonist sees up to 8% weight loss at 8 weeks in slice of early data

BrightGene’s oral dual agonist sees up to 8% weight loss at 8 weeks in slice of early data

  • March 25, 2026

China’s BrightGene has served up a slice of early-stage data to remind everyone that it has a horse in the oral obesity race.

Leave A Comment

Fields (*) Mark are Required